Quanterix Corp
NASDAQ:QTRX

Watchlist Manager
Quanterix Corp Logo
Quanterix Corp
NASDAQ:QTRX
Watchlist
Price: 4.72 USD -0.84% Market Closed
Market Cap: $220.5m

Quanterix Corp
Other Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Quanterix Corp
Other Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Items CAGR 3Y CAGR 5Y CAGR 10Y
Quanterix Corp
NASDAQ:QTRX
Other Items
$52.8m
CAGR 3-Years
367%
CAGR 5-Years
74%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Other Items
-$2.5B
CAGR 3-Years
N/A
CAGR 5-Years
-134%
CAGR 10-Years
-14%
Danaher Corp
NYSE:DHR
Other Items
-$40m
CAGR 3-Years
67%
CAGR 5-Years
71%
CAGR 10-Years
45%
Waters Corp
NYSE:WAT
Other Items
-$39.5m
CAGR 3-Years
N/A
CAGR 5-Years
15%
CAGR 10-Years
18%
Agilent Technologies Inc
NYSE:A
Other Items
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
IQVIA Holdings Inc
NYSE:IQV
Other Items
-$1.7B
CAGR 3-Years
-9%
CAGR 5-Years
-57%
CAGR 10-Years
N/A
No Stocks Found

Quanterix Corp
Glance View

Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The company is headquartered in Billerica, Massachusetts and currently employs 460 full-time employees. The company went IPO on 2017-12-07. The firm is engaged in developing ultra-sensitive digital immunoassay platforms that advance precision health for life sciences research and diagnostics. Its platforms are based on its digital Simoa detection technology. Its Simoa bead-based and planar array platforms enable customers to reliably detect protein biomarkers at extremely low concentrations in blood, serum and other fluids. Its products include HD-X Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, and 2470 Arrayer. The company also supplies NF-Light antibodies and ELISA kits, which offer solutions for the detection of neurofilament light (Nf-L) for the development of therapeutics and diagnostics for neurodegenerative conditions. Its portfolio of available kits spans multiple therapeutic areas, including cardiology, infectious disease, inflammation, neurology, and oncology. The company provides services through its Simoa Accelerator Laboratory.

QTRX Intrinsic Value
9.39 USD
Undervaluation 50%
Intrinsic Value
Price

See Also

What is Quanterix Corp's Other Items?
Other Items
52.8m USD

Based on the financial report for Dec 31, 2025, Quanterix Corp's Other Items amounts to 52.8m USD.

What is Quanterix Corp's Other Items growth rate?
Other Items CAGR 5Y
74%

The average annual Other Items growth rates for Quanterix Corp have been 367% over the past three years , 74% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett